|
David W. Gryska joined our Board of Directors in March 2005. Since December 2006, Mr. Gryska has been Senior Vice President and Chief Financial Officer of Celgene. Previously, he was a principal at Strategic Consulting Group, where he provided strategic consulting to early-stage biotechnology companies. From 1998 to 2004, Mr. Gryska was Senior Vice President and Chief Financial Officer at Scios, Inc., where he led the transaction effort for the successful sale of the company to Johnson & Johnson for $2.5 billion in February 2003. From 1993 to 1998, he served as Vice President and Chief Financial Officer at Cardiac Pathways, a company later acquired by Boston Scientific Corporation. Prior to Cardiac Pathways, Mr. Gryska served as a partner at Ernst & Young (EY). During his eleven years at EY, he focused on technology industries, with an emphasis on biotechnology and healthcare companies. He holds a B.A. in accounting and finance from Loyola University and an M.B.A. from Golden Gate University.
| 